Management of a Pregnant ALK-Positive Lung Cancer Patient With Alectinib-Induced Pneumonitis and Bilateral Globus Pallidus Necrosis Postpartum

Affiliations

• ¹ Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany; Department of Thoracic Oncology, Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL). Electronic address: tilmann.bochtler@med.uni-heidelberg.de.
• ² Department of Thoracic Oncology, Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL).
• ³ Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL); Department of Thoracic Radiology, Heidelberg, Germany.
• ⁴ Department of Neurooncology, University Hospital Heidelberg, Heidelberg, Germany.
• ⁵ Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.